| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |